127 related articles for article (PubMed ID: 5818230)
1. Investigation of endocrine exophthalmos.
Bowden AN; Ross FC
Proc R Soc Med; 1969 Jan; 62(1):13-5. PubMed ID: 5818230
[No Abstract] [Full Text] [Related]
2. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
3. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
4. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
5. Thyroid physiology and functional tests.
Zellmann HE
Major Probl Clin Surg; 1980; 15():70-84. PubMed ID: 6893732
[No Abstract] [Full Text] [Related]
6. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
Hall R; Kirkham K; Doniach D; el-Kabir D
Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
[No Abstract] [Full Text] [Related]
7. Thyroid gland in Graves' disease: victim or culprit?
Chopra IJ; Solomon DH; Johnson DE; Chopra U
Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
[No Abstract] [Full Text] [Related]
8. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Chopra IJ; Chopra U; Orgiazzi J
J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
[No Abstract] [Full Text] [Related]
9. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
10. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
[No Abstract] [Full Text] [Related]
11. Mechanisms of Graves' disease and endocrine exophthalmos.
Anderson DR
Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
[No Abstract] [Full Text] [Related]
12. Endocrine exophthalmos: an immunologic aberration.
Kaplan HJ
Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
[No Abstract] [Full Text] [Related]
13. Modern examination methods of orbital disease. Thyroid exophthalmos.
Wilber JF
Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(4):OP568-70. PubMed ID: 4277577
[No Abstract] [Full Text] [Related]
14. Thyroid physiology and functional tests.
Zellmann HE
Major Probl Clin Surg; 1974; 15(0):55-70. PubMed ID: 4138680
[No Abstract] [Full Text] [Related]
15. Pretibial myxedema and nonthyrotoxic thyroid disease.
Lynch PJ; Maize JC; Sisson JC
Arch Dermatol; 1973 Jan; 107(1):107-11. PubMed ID: 4118738
[No Abstract] [Full Text] [Related]
16. Thyroid responsiveness in Gravesian ophthalmopathy.
Mendelsohn LV; Mouton DE; Goldzieher JW
Arch Intern Med; 1972 Jul; 130(1):119-20. PubMed ID: 5067864
[No Abstract] [Full Text] [Related]
17. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
18. Effect of thyroid ablation on dysthyroid exophthalmos.
Boyle IT; Greig WR; Thomson JA; Winning J; McGirr EM
Proc R Soc Med; 1969 Jan; 62(1):19-23. PubMed ID: 5818232
[No Abstract] [Full Text] [Related]
19. [Evolution of iodine uptake, PBI-131, PBI-127 and clinical symptoms following administration of triiodothyronine to subjects with hyperthyroidism caused by diffuse thyroid hyperplasia. Role of the lymphatic system and LATS in the effect of Graves disease stimulation].
Mahaux JE; Chamla-Soumenkof J; Nagel M; Levin S
Ann Endocrinol (Paris); 1968; 29(4):483-95. PubMed ID: 5756676
[No Abstract] [Full Text] [Related]
20. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Wils JA; Kloppenborg PW
J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
